Skip to main content

Security report for santhera.de

Santhera Pharmaceuticals · Healthcare · Switzerland

Medium risk. 6 critical or high findings in Email security, Security headers and 1 other check.

Security score

52/100

Risk levelMedium

0–100, higher is better. How it is calculated

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company focused on the research, development, and commercialization of medicines for patients with rare diseases, particularly neuromuscular and mitochondrial disorders. The website targets patients, healthcare professionals, investors, and potential employees, providing comprehensive information about the company, its research, products, and corporate governance. The digital infrastructure employs modern technologies such as jQuery, Google Tag Manager, and OneTrust for cookie consent management, hosted on servers indicated by the domain's nameservers. The website is well-structured, mobile-optimized, and provides a professional user experience with clear navigation and relevant content. Security posture is solid with HTTPS enforced and cookie consent mechanisms in place, though explicit security policies and incident response contacts are not published. WHOIS data is consistent with the company's claims, showing legitimate domain registration and no privacy protection, supporting the site's credibility. Overall, the website demonstrates a mature digital presence suitable for a pharmaceutical company, with room for improvement in security transparency and contact information availability.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching santhera.de

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
20
Email security
40
DNS health
60
Network security
40
GDPR outside view
88
Average
52

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Santhera operates in the niche pharmaceutical sector specializing in rare diseases, which positions it uniquely in a market with high unmet medical needs. The company leverages research and development as its core business model, targeting patients with severe neuromuscular conditions. The website reflects a focus on transparency and investor relations, with dedicated sections for media, investors, and career opportunities, indicating a growth-oriented and stakeholder-inclusive approach. The absence of direct contact details on the main pages suggests a controlled communication strategy, possibly to manage inquiries through specific channels. The use of cookie consent and GDPR-compliant policies aligns with regulatory requirements in the EU and Switzerland, enhancing trust among European users. The company’s digital ecosystem includes partnerships with external service providers for analytics and consent management, but no suspicious or unrelated domains are linked, indicating a clean and focused online presence.

Security posture

The website enforces HTTPS, ensuring encrypted communication and protecting user data in transit. Cookie consent is implemented with granular user controls, demonstrating compliance with privacy regulations such as GDPR. However, the absence of published security policies and incident response contacts limits transparency and may hinder user confidence in security incident handling. No security headers were explicitly detected in the provided data, suggesting an opportunity to enhance HTTP security configurations. The use of third-party scripts like Google Tag Manager and OneTrust is standard but requires ongoing monitoring to mitigate supply chain risks. No vulnerabilities or exposed sensitive data were identified in the analysis. Overall, the security posture is good but could be improved by publishing security policies, adding security headers, and providing clear incident response contacts.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and controls.
  2. Provide explicit incident response contact information such as security@ or abuse@ email addresses.
  3. Implement and enforce HTTP security headers including Content-Security-Policy, X-Content-Type-Options, and Strict-Transport-Security.
  4. Regularly audit and update third-party scripts to mitigate supply chain vulnerabilities.
  5. Enhance contact information availability to improve user trust and communication.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Santhera Pharmaceuticals
Description
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
Key services
Research and development of medicines, Commercialization of therapies for rare neuromuscular diseases
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Google Tag Manager, OneTrust Cookie Consent
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner with granular controls

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Cookie consent is implemented with granular user controls.
  3. No direct contact emails or phone numbers found on the homepage or footer.
  4. No explicit security policy or incident response information published.
  5. WHOIS data is consistent and supports legitimacy.
  6. No signs of WAF or content blocking.
  7. Content is focused on pharmaceutical research and patient support.
Technical notes

Notes

The website uses a modern and standard technology stack including jQuery for DOM manipulation, Google Tag Manager for analytics and tag management, and OneTrust for cookie consent compliance. The site loads external fonts from Google Fonts, enhancing typography. Hosting appears to be managed via your-server.de and related nameservers, indicating a dedicated hosting environment. Performance is moderate with no explicit indicators of slow loading, and the site is mobile-optimized with responsive design elements. Accessibility is basic but present, with semantic HTML and ARIA labels in consent dialogs. SEO optimization is good, with appropriate meta tags including description and viewport settings. There is no detected CMS from the provided data, suggesting a custom or proprietary platform. Overall, the technical infrastructure supports a professional and compliant web presence with opportunities for further modernization and security hardening.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with santhera.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review santhera.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.